A Comparison of ThermaWedge™ Device and Achilles Tendon Stretching for the Treatment of Plantar Fasciopathy

Not Applicable

Completed

Brief Summary: The investigators will compare Achilles tendon stretching with a new product called a ThermaWedge™ device, a foam wedge designed to help with certain foot stretches and exercises, in the treatment of chronic plantar fasciopathy. There will be 2 groups each of 25 - 30 participants who have chronic plantar fasciopathy, which is a common cause of foot pain. Exercises will be done for 6 weeks and then each group will do the other exercise protocol for another 6 weeks. Participants will fill out the Foot and Ankle Disability Index scale and numerical analog pain scale and the Global Rating of Change Scale prior to any treatment, weekly during treatment and post treatment. The investigators' hypothesis is that use of the ThermaWedge™ device will result in decreased pain and disability when compared to achilles tendon stretching.

Recruitment & Eligibility

Inclusion Criteria

diagnosis of plantar fasciopathy which has persisted (chronic) for at least 12 months.
participants need to be able to understand simple instructions about the stretches which will likely include both verbal instructions and pictures and participants need to be able to do all the necessary exercises.
Participants must have current British Columbia (BC) Medical Service Plan (MSP) health coverage so that if they become injured, they are covered medically.
Participants must be able to fill out surveys online.
Participants must also pass a clinical screen where a senior medical student or a physiotherapist, Scott Fraser, will assess the patient for for plantar fasciopathy/fasciitis.

Exclusion Criteria

Previous ankle or foot trauma or surgery
duration of pain of less than 12 months,
those receiving adjuvant treatment such as injections during the time of the study,
those who are unable to do the necessary exercises required in the study
Those who do not have current BC MSP health insurance coverage.

Arm && Interventions

Group	Intervention	Description
ThermaWedge TM	ThermaWedge TM	This is the arm of participants who will first be assigned to perform 6 weeks of ThermaWedge TM stretching as demonstrated in the protocol. As this is a crossover design study this arm will then switch to 6 weeks of Achilles Tendon Stretching
ThermaWedge TM	Achilles Tendon Stretching	This is the arm of participants who will first be assigned to perform 6 weeks of ThermaWedge TM stretching as demonstrated in the protocol. As this is a crossover design study this arm will then switch to 6 weeks of Achilles Tendon Stretching
Achilles Tendon Stretching	Achilles Tendon Stretching	This is the arm of participants who will first be assigned to perform 6 weeks of achilles tendon stretching as demonstrated in the protocol. As this is a crossover design study, this arm will then switch to 6 weeks of ThermaWedge TM stretching.
Achilles Tendon Stretching	ThermaWedge TM	This is the arm of participants who will first be assigned to perform 6 weeks of achilles tendon stretching as demonstrated in the protocol. As this is a crossover design study, this arm will then switch to 6 weeks of ThermaWedge TM stretching.

Primary Outcome Measures

Name	Time	Method
Numerical Rating Scale - assessing change in severity of pain	The participants will use the scale on day 1 of the study, at weeks 1, 2 ,3 ,4 ,5, 6, 7, 8, 9, 10, 11, and 12, as well as 6 and 12 weeks after the completion of the intervention	This is a rating scale on which patients will rate the severity of the worst pain they have experienced in the last week from 0-10.
Foot and Ankle Disability Index - assessing change in disability	The participants will use the scale on day 1 of the study, at weeks 1, 2 ,3 ,4 ,5, 6, 7, 8, 9, 10, 11, and 12, as well as 6 and 12 weeks after the completion of the intervention	This is a questionnaire that assesses the amount of pain and the level of functioning that patient is currently experiencing with respect to the foot and ankle.
Global Rating of Change Scale - assessing change in pain and function	The participants will use the scale on day 1 of the study, at weeks 1, 2 ,3 ,4 ,5, 6, 7, 8, 9, 10, 11, and 12, as well as 6 and 12 weeks after the completion of the intervention	This is a rating scale which allows participants to indicate the degree of change in pain/function that the participant has experienced since the start of the intervention

Secondary Outcome Measures

Name	Time	Method

Locations (1): University of British Columbia
🇨🇦
Vancouver, British Columbia, Canada